Tag: Glargine
Biocon Biologics successfully completes integration of Viatris’ biosimilar business in 31...
In Europe, Biocon Biologics portfolio includes 7 biosimilars: Insulin Aspart and Insulin Glargine, Bevacizumab, Pegfilgrastim, Trastuzumab, Adalimumab, and Etanercept
Biocon’s Insulin, Glargine gets green signal from Japanese regulatory agency
The product is a ready-to-use, prefilled disposable pen with 3 ml of 100IU Insulin Glargine..